Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vedolizumab”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT03577782
What this trial is testing

Vedolizumab Treatment in HIV-Infected Subjects Without Previous Antiretroviral Therapy

Who this might be right for
HIV Infections
Hospitales Universitarios Virgen del Rocío 12
Large-scale testing (Phase 3)Active Not RecruitingNCT06880744
What this trial is testing

Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to Vedolizumab

Who this might be right for
Ulcerative Colitis
AbbVie 573
Large-scale testing (Phase 3)Active Not RecruitingNCT04738942
What this trial is testing

Intravenous Vedolizumab Administered Every 4 Weeks in Japanese Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease

Who this might be right for
Ulcerative ColitisCrohn's Disease
Takeda 56
Not applicableUnknownNCT05158517
What this trial is testing

VeDOlizumab PERsistence in IBD Patients After Switching From Intravenous to Subcutaneous Administration : a Real-life Multicenter Study (DOPER)

Who this might be right for
Inflammatory Bowel Diseases
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives 349
Not applicableStudy completedNCT02694588
What this trial is testing

Clinical and Molecular Phenotyping in IBD

Who this might be right for
IBD
University Hospital Schleswig-Holstein 90
Post-approval studies (Phase 4)Study completedNCT03679546
What this trial is testing

EFFICACI : EFFicacy of Intravenous Infliximab Versus Vedolizumab After Failure of subCutaneous Anti-TNF in Patients With UlCerative Colitis

Who this might be right for
Ulcerative Colitis
Rennes University Hospital 151
Large-scale testing (Phase 3)Looking for participantsNCT06227910
What this trial is testing

Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease

Who this might be right for
Crohn's Disease
Takeda 396
Large-scale testing (Phase 3)Study completedNCT00783692
What this trial is testing

Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Crohn's Disease

Who this might be right for
Crohn's Disease
Millennium Pharmaceuticals, Inc. 1,116
Post-approval studies (Phase 4)Ended earlyNCT02324699
What this trial is testing

Corticosteroids With Vedolizumab in Crohn's Disease

Who this might be right for
Crohn's Disease
Icahn School of Medicine at Mount Sinai 1
Testing effectiveness (Phase 2)Ended earlyNCT02993783
What this trial is testing

A Dose-Finding Study of Vedolizumab for Treatment of Steroid-Refractory Acute Intestinal Graft-Versus-Host Disease (GvHD) in Participants Who Have Undergone Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT)

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation
Millennium Pharmaceuticals, Inc. 17
Large-scale testing (Phase 3)Study completedNCT02620046
What this trial is testing

Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's Disease

Who this might be right for
Colitis, UlcerativeCrohn's Disease
Takeda 746
Testing effectiveness (Phase 2)Looking for participantsNCT05327790
What this trial is testing

LFMT vs Placebo in New Biologic Start for Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
University of Alberta 40
Large-scale testing (Phase 3)Looking for participantsNCT05837897
What this trial is testing

Vedolizumab in Adult Participants With Moderate to Severe Crohn's Disease

Who this might be right for
Crohn's Disease
Takeda 408
Post-approval studies (Phase 4)Ended earlyNCT02743806
What this trial is testing

Extended Access Program of Vedolizumab IV in Ulcerative Colitis and Crohn's Disease

Who this might be right for
Colitis, UlcerativeCrohn Disease
Takeda 331
Not applicableUnknownNCT04362735
What this trial is testing

Efficacy of Vedolizumab in Crohn's Disease Patients Naive to Biological Therapy

Who this might be right for
Crohn Disease
Pontifícia Universidade Católica do Paraná 100
Post-approval studies (Phase 4)Not Yet RecruitingNCT06788340
What this trial is testing

MOdel-Informed Precision Dosing of Ustekinumab and VEdolizumab in Inflammatory Bowel Disease

Who this might be right for
Inflammatory Bowel DiseasesCrohn DiseaseUlcerative Colitis
Odense University Hospital 166
Not applicableStudy completedNCT05649462
What this trial is testing

Effect of Vitamin D Supplementation on Vedolizumab Response in Patients With Ulcerative Colitis

Who this might be right for
Ulcerative ColitisVitamin D DeficiencyVitamin D Supplement
Second Affiliated Hospital of Wenzhou Medical University 80
Post-approval studies (Phase 4)UnknownNCT04006080
What this trial is testing

Investigation of the Faecal Loss of Vedolizumab and Its Role in Influencing Serum Drug Levels, Outcomes and Response in Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Guy's and St Thomas' NHS Foundation Trust 30
Not applicableStudy completedNCT04872491
What this trial is testing

Vedolizumab in Adults in Real-World Practice

Who this might be right for
Colitis, UlcerativeCrohn Disease
Takeda 500
Testing effectiveness (Phase 2)Study completedNCT03196427
What this trial is testing

Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)

Who this might be right for
Ulcerative ColitisCrohn's Disease
Takeda 59
Next Page